MedTrace Logo

Comparing 6-Minute Walk Tests for Ambulatory Oxygen Assessment

NCT05630092 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2026-04-20

Study results available
· View outcomes & findings →

Summary

Patients with lung disease who report breathlessness on exertion are often referred for a 6MWT. Due to the nature of the 6MWT (hereon referred to as a Max-6MWT), patients are required to walk as far as they can in 6 minutes. This may lead to an inaccurate assessment of their requirement for ambulatory oxygen as this form of exercise may not correspond to their normal daily activities.

In this study, patients who are routinely referred for a Max-6MWT to investigate possible exercise-induced hypoxaemia will be invited to perform an additional walking test which is performed at their normal walking speed, referred here on in as a Nor\_6MWT. We hypothesise that performing a Nor\_6MWT will provide a more accurate assessment of a patients' oxygen requirement, primarily from their oxygen desaturation during the test.

Conditions

  • Respiratory Disease

Interventions

DIAGNOSTIC_TEST

Maximal 6-minute Walk Test (Max_6MWT)

Instructions given to perform the walk test following the international guidelines using the phrase 'as far as you can'.

DIAGNOSTIC_TEST

Normal speed 6-minute Walk Test (Nor_6MWT)

Instructions given to perform the walk test following the international guidelines except using the phrase 'at a speed you would normally walk'.

Sponsors & Collaborators

  • Hampshire Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Harry Griffin, PhD · Hampshire Hospitals NHS Foundation Trust

  • Michael J Hughes, PhD · Hampshire Hospitals NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-02-23
Completion
2024-05-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630092 on ClinicalTrials.gov